<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns="http://purl.org/rss/1.0/"
         xmlns:admin="http://webns.net/mvcb/"
         xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
  <channel rdf:about="https://hstalks.com/rss/by-category/758/">
    <title>Immunology</title>
    <link>https://hstalks.com/category/758/immunology/?biosci</link>
    <description>New and updated series &amp; talks on Immunology from HSTalks&#x27; Biomedical &amp; Life Sciences Collection.</description>
    <admin:generatorAgent rdf:resource="http://www.hstalks.com/" />
    <admin:errorReportsTo rdf:resource="mailto:info@hstalks.com" />
    <sy:updatePeriod>daily</sy:updatePeriod>
    <sy:updateFrequency>1</sy:updateFrequency>
    <sy:updateBase>2006-01-01T12:00+00:00</sy:updateBase>
    <dc:publisher>Henry Stewart Talks</dc:publisher>
    <dc:language>en</dc:language>
    <dc:rights>© Copyright Henry Stewart Talks Ltd.</dc:rights>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
    <prism:copyright>© Copyright Henry Stewart Talks Ltd.</prism:copyright>
    <items>
      <rdf:Seq>
      <rdf:li resource="https://hstalks.com/t/22102/walking-on-water-load-bearing-joint-perfusion-and-/?biosci" />
      <rdf:li resource="https://hstalks.com/t/27038/chronic-inflammation-mechanisms/?biosci" />
      <rdf:li resource="https://hstalks.com/t/12763/bladder-cancer-types-risk-factors-diagnosis-treatm/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20353/the-evolving-landscape-of-sepsis-from-empiricism-t/?biosci" />
      <rdf:li resource="https://hstalks.com/t/23686/blood-cleansing-as-immunotherapy-testing-a-novel-c/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21475/psoriasis-diagnosis-overview/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21739/understanding-c-difficile-from-microbes-to-managem/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21244/oxidative-stress-and-disease-atherosclerosis/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20452/gastrointestinal-lymphatics-nutrient-absorption-im/?biosci" />
      <rdf:li resource="https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci" />
      <rdf:li resource="https://hstalks.com/t/24751/antibody-drug-conjugates-adcs/?biosci" />
      <rdf:li resource="https://hstalks.com/t/22960/immunotherapy-in-cancer-research-recent-advancemen/?biosci" />
      <rdf:li resource="https://hstalks.com/t/24752/inflammation/?biosci" />
      
      </rdf:Seq>
    </items>
  </channel>

  <item rdf:about="https://hstalks.com/t/22102/walking-on-water-load-bearing-joint-perfusion-and-/?biosci">
    <title>Walking on water: load bearing, joint perfusion and osteoarthritis [24 mins] </title>
    <link>https://hstalks.com/t/22102/walking-on-water-load-bearing-joint-perfusion-and-/?biosci</link>
    <description>Joints - IOP measurement - Factor affecting IOP measurements - Significance of IOPv - IOPa - Load - Vascular markings in MRI scans - Correlation between vascular marks and Kellgren - Lawrence grade - Bone histology - Choke valve</description>
    <dc:title>Walking on water: load bearing, joint perfusion and osteoarthritis</dc:title>
    
    <dc:creator>Dr. Michael Beverly</dc:creator>
    
    <dc:subject>Joints, IOP measurement, Factor affecting IOP measurements, Significance of IOPv, IOPa, Load, Vascular markings in MRI scans, Correlation between vascular marks and Kellgren, Lawrence grade, Bone histology, Choke valve</dc:subject>
    <dc:date>2026-09-30</dc:date>
    <prism:publicationDate>2026-09-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/27038/chronic-inflammation-mechanisms/?biosci">
    <title>Chronic inflammation mechanisms [4 mins] </title>
    <link>https://hstalks.com/t/27038/chronic-inflammation-mechanisms/?biosci</link>
    <description>Chronic inflammation mechanisms - Acute vs chronic inflammation - Cellular and molecular pathways - Key cytokines and immune cells - Chronic inflammation in diseases - Innate and adaptive immunity roles - Therapeutic approaches and immune modulation</description>
    <dc:title>Chronic inflammation mechanisms</dc:title>
    
    
    <dc:subject>Chronic inflammation mechanisms, Acute vs chronic inflammation, Cellular and molecular pathways, Key cytokines and immune cells, Chronic inflammation in diseases, Innate and adaptive immunity roles, Therapeutic approaches and immune modulation</dc:subject>
    <dc:date>2026-09-30</dc:date>
    <prism:publicationDate>2026-09-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/12763/bladder-cancer-types-risk-factors-diagnosis-treatm/?biosci">
    <title>Bladder cancer: types, risk factors, diagnosis, treatment and prevention: further clinical trials [37 mins] </title>
    <link>https://hstalks.com/t/12763/bladder-cancer-types-risk-factors-diagnosis-treatm/?biosci</link>
    <description>Ongoing clinical trials for bladder cancer - Enfortumab-vedotin &amp; pembrolizumab as first-line therapy - Disitamab vedotin &amp; toripalimab (PD1 inhibitor) for the treatment of metastatic UC - Erdafitinib for the treatment of metastatic UC with FGFR2/3 mutations/fusions - Remission with cisplatin-based NAC - mRNA-4157 (V940): customizable individualized mRNA immunotherapy - Adjuvant chemotherapy - Neoadjuvant Chemo-IO combination therapy</description>
    <dc:title>Bladder cancer: types, risk factors, diagnosis, treatment and prevention: further clinical trials</dc:title>
    
    <dc:creator>Prof. Guru P. Sonpavde</dc:creator>
    
    <dc:subject>Ongoing clinical trials for bladder cancer, Enfortumab-vedotin &amp; pembrolizumab as first-line therapy, Disitamab vedotin &amp; toripalimab (PD1 inhibitor) for the treatment of metastatic UC, Erdafitinib for the treatment of metastatic UC with FGFR2/3 mutations/fusions, Remission with cisplatin-based NAC, mRNA-4157 (V940): customizable individualized mRNA immunotherapy, Adjuvant chemotherapy, Neoadjuvant Chemo-IO combination therapy</dc:subject>
    <dc:date>2026-09-30</dc:date>
    <prism:publicationDate>2026-09-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20353/the-evolving-landscape-of-sepsis-from-empiricism-t/?biosci">
    <title>The evolving landscape of sepsis: from empiricism to precision medicine [59 mins] </title>
    <link>https://hstalks.com/t/20353/the-evolving-landscape-of-sepsis-from-empiricism-t/?biosci</link>
    <description></description>
    <dc:title>The evolving landscape of sepsis: from empiricism to precision medicine</dc:title>
    
    <dc:creator>Prof. Ignacio Martin-Loeches</dc:creator>
    
    <dc:subject></dc:subject>
    <dc:date>2026-09-21</dc:date>
    <prism:publicationDate>2026-09-21</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/23686/blood-cleansing-as-immunotherapy-testing-a-novel-c/?biosci">
    <title>Blood cleansing as immunotherapy: testing a novel cancer vaccine strategy [18 mins] </title>
    <link>https://hstalks.com/t/23686/blood-cleansing-as-immunotherapy-testing-a-novel-c/?biosci</link>
    <description>Cancer vaccines - Cancer immunotherapy - Ovarian cancer - Tumour antigens - Whole-cell vaccines - T-cell activation - Tumour microenvironment - Clinical development of immunotherapies</description>
    <dc:title>Blood cleansing as immunotherapy: testing a novel cancer vaccine strategy</dc:title>
    
    <dc:creator>Prof. Raymond Goodrich</dc:creator>
    
    <dc:subject>Cancer vaccines, Cancer immunotherapy, Ovarian cancer, Tumour antigens, Whole-cell vaccines, T-cell activation, Tumour microenvironment, Clinical development of immunotherapies</dc:subject>
    <dc:date>2026-08-31</dc:date>
    <prism:publicationDate>2026-08-31</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21475/psoriasis-diagnosis-overview/?biosci">
    <title>Psoriasis: diagnosis &amp; overview [38 mins] </title>
    <link>https://hstalks.com/t/21475/psoriasis-diagnosis-overview/?biosci</link>
    <description>Clinical identification of psoriasis - Pathogenesis - Classification of psoriasis - Psoriatic arthritis - Enthesitis - Comorbidities in psoriatic disease - Malignancy and psoriasis - Quality of life in psoriasis</description>
    <dc:title>Psoriasis: diagnosis &amp; overview</dc:title>
    
    <dc:creator>Dr. Tina Bhutani</dc:creator>
    
    <dc:subject>Clinical identification of psoriasis, Pathogenesis, Classification of psoriasis, Psoriatic arthritis, Enthesitis, Comorbidities in psoriatic disease, Malignancy and psoriasis, Quality of life in psoriasis</dc:subject>
    <dc:date>2026-08-31</dc:date>
    <prism:publicationDate>2026-08-31</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21739/understanding-c-difficile-from-microbes-to-managem/?biosci">
    <title>Understanding C. difficile: from microbes to management [41 mins] </title>
    <link>https://hstalks.com/t/21739/understanding-c-difficile-from-microbes-to-managem/?biosci</link>
    <description>Clostridioides (Clostridium) difficile a healthcare associated pathogen - C. difficile transmission - C. difficile spore germination - C. difficile spores: A therapeutic target - Microbiome based therapies (MBTs) - Fecal microbiota transplantation (FMT)</description>
    <dc:title>Understanding C. difficile: from microbes to management</dc:title>
    
    <dc:creator>Dr. Anna Seekatz</dc:creator>
    
    <dc:subject>Clostridioides (Clostridium) difficile a healthcare associated pathogen, C. difficile transmission, C. difficile spore germination, C. difficile spores: A therapeutic target, Microbiome based therapies (MBTs), Fecal microbiota transplantation (FMT)</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21244/oxidative-stress-and-disease-atherosclerosis/?biosci">
    <title>Oxidative stress and disease: atherosclerosis [27 mins] </title>
    <link>https://hstalks.com/t/21244/oxidative-stress-and-disease-atherosclerosis/?biosci</link>
    <description>Reactive oxygen species - Redox signaling - Consequences of oxidative stress - Atherosclerosis - Oxidative stress and atherosclerosis - Oxidative stress targeted therapies</description>
    <dc:title>Oxidative stress and disease: atherosclerosis</dc:title>
    
    <dc:creator>Dr. Arthur Almeida</dc:creator>
    
    <dc:subject>Reactive oxygen species, Redox signaling, Consequences of oxidative stress, Atherosclerosis, Oxidative stress and atherosclerosis, Oxidative stress targeted therapies</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20452/gastrointestinal-lymphatics-nutrient-absorption-im/?biosci">
    <title>Gastrointestinal lymphatics: nutrient absorption, immunity, and disease [23 mins] </title>
    <link>https://hstalks.com/t/20452/gastrointestinal-lymphatics-nutrient-absorption-im/?biosci</link>
    <description>Gut lymphatic architecture - Gut lymphatic functions - Button vs. zipper junctions - Chylomicron entry in lacteals - Dysfunction of gut lymphatic vessels - How lymphatic flow and absorption are controlled in the digestive system</description>
    <dc:title>Gastrointestinal lymphatics: nutrient absorption, immunity, and disease</dc:title>
    
    <dc:creator>Dr. Vincenza Cifarelli</dc:creator>
    
    <dc:subject>Gut lymphatic architecture, Gut lymphatic functions, Button vs. zipper junctions, Chylomicron entry in lacteals, Dysfunction of gut lymphatic vessels, How lymphatic flow and absorption are controlled in the digestive system</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci">
    <title>Pathophysiology and management of chronic inflammatory demyelinating polyneuropathy [26 mins] </title>
    <link>https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci</link>
    <description>Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - CIDP pathology - CIDP immunopathogenesis - CIDP treatment goals - Intravenous immunoglobulin (IVIG) - Plasma exchange (PLEX) - Corticosteroid (CSS) - Subcutaneous immunoglobulin (SCIG) - Neonatal Fc receptor inhibitors - Complement inhibitors</description>
    <dc:title>Pathophysiology and management of chronic inflammatory demyelinating polyneuropathy</dc:title>
    
    <dc:creator>Prof. Urvi Desai</dc:creator>
    
    <dc:subject>Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), CIDP pathology, CIDP immunopathogenesis, CIDP treatment goals, Intravenous immunoglobulin (IVIG), Plasma exchange (PLEX), Corticosteroid (CSS), Subcutaneous immunoglobulin (SCIG), Neonatal Fc receptor inhibitors, Complement inhibitors</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/24751/antibody-drug-conjugates-adcs/?biosci">
    <title>Antibody-drug conjugates (ADCs) [4 mins] </title>
    <link>https://hstalks.com/t/24751/antibody-drug-conjugates-adcs/?biosci</link>
    <description>Antibody-drug conjugate concept - ADC structure and components - Targeted cancer cell delivery - Clinical ADC applications - ADC benefits over standard cancer therapy - Challenges in ADC development - Future directions in personalized medicine</description>
    <dc:title>Antibody-drug conjugates (ADCs)</dc:title>
    
    
    <dc:subject>Antibody-drug conjugate concept, ADC structure and components, Targeted cancer cell delivery, Clinical ADC applications, ADC benefits over standard cancer therapy, Challenges in ADC development, Future directions in personalized medicine</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/22960/immunotherapy-in-cancer-research-recent-advancemen/?biosci">
    <title>Immunotherapy in cancer research: recent advancements (2026) [10 mins] </title>
    <link>https://hstalks.com/t/22960/immunotherapy-in-cancer-research-recent-advancemen/?biosci</link>
    <description>Cancer immunotherapy - Immune checkpoint blockade - Personalized cancer vaccines - CAR-T &amp; TCR cell therapy - Bispecific T-cell engagers - Biomarker discovery - AI &amp; multi-omics in oncology - Glioblastoma and tumor microenvironment</description>
    <dc:title>Immunotherapy in cancer research: recent advancements (2026)</dc:title>
    
    <dc:creator>Prof. Mustafa Khasraw</dc:creator>
    
    <dc:subject>Cancer immunotherapy, Immune checkpoint blockade, Personalized cancer vaccines, CAR-T &amp; TCR cell therapy, Bispecific T-cell engagers, Biomarker discovery, AI &amp; multi-omics in oncology, Glioblastoma and tumor microenvironment</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/24752/inflammation/?biosci">
    <title>Inflammation [4 mins] </title>
    <link>https://hstalks.com/t/24752/inflammation/?biosci</link>
    <description>Overview of inflammation - Acute vs. chronic inflammation - Cellular and molecular inflammation - Clinical signs of inflammation - Inflammation management strategies</description>
    <dc:title>Inflammation</dc:title>
    
    
    <dc:subject>Overview of inflammation, Acute vs. chronic inflammation, Cellular and molecular inflammation, Clinical signs of inflammation, Inflammation management strategies</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

</rdf:RDF>
